Page 31 - Anjali Singh

Indian firms fared better in USFDA inspections in recent years, says IPA

IPA bats for Revised Schedule M implementation as key to pharma manufacturing quality in India

Shifting gears: Ather Energy plans new facility in Maharashtra's Bidkin

The company aims to diversify manufacturing base to enhance proximity to key markets across India and streamline operational costs

Dr. Reddy's to acquire Haleon's nicotine replacement biz for 500 mn pounds

The acquisition includes Nicotinell, a global leader in the NRT category, and its local market-leading brand names Nicabate, Habitrol, and Thrive

RR Global-backed BGauss aims for major EV market share riding on RUV350

The company envisions EV-2W category will maintain a 60 per cent market share by 2030, with the RUV category capturing around 25 to 30 per cent of the market

Hero MotoCorp to hike prices of motorcycles, scooters from July 1

Price rise would be upto Rs 1500 varying with models

Musashi India to ramp up EV component localisation to 70% by year-end

The company aims to produce 1 million e-axles per year by 2030 to accelerate India's transition to green mobility

Uttarakhand's ghost villages, a side story to the Lok Sabha elections

For decades, the hills have witnessed consistent exodus. Will the tide reverse anytime soon?

Tata Motors Fleet Verse: A comprehensive digital marketplace for CVs

Fleet Verse has five key features to ensure a comprehensive and user-friendly experience for customers

TaMo announces third price hike for CVs in 2024 amid rising commodity costs

The hike will be applicable across the entire range of commercial vehicles, with variations depending on individual models and variants

Nepal's drug regulator bans sale of Indian antibiotic over quality issues

Zydus Lifesciences said the reports were 'misleading and erroneous'

Domestic drugs formulations market to be worth Rs 5.5 trn by 2034: Report

'Significant under-penetration' in domestic market, especially in smaller towns and rural areas

Cipla to invest additional 3 mn euro in mRNA technology company Ethris

The aim is to accelerate Cipla's entry into the mRNA space and deliver innovative mRNA-based therapies, particularly targeting respiratory treatments, to patients in emerging markets

Three-wheeler exports may continue to skid in FY25 over subdued demand

As such three wheeler exports have been declining. According to SIAM data, in FY23, exports fell by 26 per cent, followed by a 17 percent fall in FY24

Lupin appoints Abdelaziz Toumi as CEO of newly established subsidiary LMS

LMS will focus on the development, manufacture, and sale of Active Pharmaceutical Ingredients (APIs) while expanding into the Contract Development and Manufacturing Operations (CDMO) business

Up against 60 days' inventory, car dealers seek Siam's intervention

The 60-day inventory levels are close to the 2018-19 levels when inventory inventory days had neared 70 days, and around 282 passenger vehicle dealerships had shut shop

Pharma's eco pill: Sustainable packaging as new prescription for planet

Merck also revealed that they are investing in renewable energy sources, and half of their Mumbai facility's energy is now sourced from solar panels

Kotak Alt invests Rs 1,445 cr to acquire Viatris API biz for Matrix Pharma

This acquisition will make Matrix the second-largest Indian active pharmaceutical ingredients (API) player with global leadership in antiretroviral (ARV) APIs

Daimler India names Muthu Maruthachalam as new chief of ops, logistics

Muthumaruthachalam began his career with DICV in 2009 as a specialist in heavy-duty truck project management

Pharma companies step up use of advanced technologies to improve processes

Industry is using AI and digital tools to improve processes and help patients

Domestic commercial vehicle sales likely to dip 4-7% in FY25: ICRA

In February 2024, the industry saw a slight 0.7 per cent year-on-year decline in wholesale volumes, although it managed a 5.1 per cent sequential growth